Urinary incontinence has three main subtypes including stress, urge and mixed, and is estimated to affect 100 million women in the seven major markets. Drug therapy for urinary incontinence has focused on overactive bladder, worth over $1.3 billion in

This report examines the four major female disorders: hormone replacement therapy, osteoporosis, hormonal contraception and female sexual dysfunction.

An enhanced understanding of disease biology offers developers the opportunity to use niche markets such as myeloma as a reduced-risk pathway to the commercialization of molecular-targeted treatments. The identification of prospective clinical, regulat

Although there are a huge number of individuals who report having the symptoms of RLS, this neurological disorder remains inadequately diagnosed and treated. There are plenty of opportunities in this market for pharmaceutical manufacturers, but raising

Increased prevalence of diabetes, obesity, and cardiovascular disease, all causal factors of renal disease, drives growth of the end-stage renal disease (ESRD) sector. On average, an ESRD patient uses >$7,000 of drugs/year, representing a significant o